| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.05 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.062 | 0.05 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.05 |